Navigation Links
Deep sequencing of breast cancer tumors to predict clinical outcomes after single dose of therapy
Date:12/12/2013

CLEVELAND: New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients.

Results showed that through deep genome sequencing, a reduction in the most commonly mutated genes in breast cancer could be observed after just one dose of preoperative therapy. Deep sequencing is a process that involves sequencing the same region multiple times to identify mutations within tumors that have an importance in cancer evolution. These new findings were presented during the 2013 San Antonio Breast Cancer Symposium.

"Genomics is the new frontier of cancer research, and this study shows that we may be able to accurately determine what treatment methods will and will not be effective for individual patients after just one dose of medicine," said Lyndsay Harris, MD, study investigator and Director, Breast Cancer Program, UH Seidman Cancer Center and Professor of Medicine at Case Western Reserve University School of Medicine. "The ability to understand potential clinical outcomes for patients earlier in the treatment process would provide physicians with better opportunity to personalize patients' medicines according to their own tumor responses."

More than 209,000 patients in the U.S. are diagnosed with breast cancer each year. The anticipated outcome of studying the genetic makeup of breast cancer patients is to determine who will benefit most from certain drug therapies and to use that information to create a personalized treatment plan for each patient involved. Dr. Harris and team are currently integrating whole genome profiles with deep sequencing data as they spearhead a new study at UH Seidman Cancer Center to validate these initial findings presented in San Antonio. <
'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
216-844-5158
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Powerful sequencing technology decodes DNA folding pattern
2. Sequencing works in clinical setting to help -- finally -- get a diagnosis
3. The sequencing of the tomato genome
4. DNA Sequencing: Emerging Technologies and Applications
5. Next-generation sequencing technology opens doors to discoveries
6. University of North Texas Health Science Center Advances Forensic Research by Investing in Semiconductor DNA Sequencing Technology
7. Exome sequencing gives cheaper, faster diagnosis in heterogeneous disease
8. An error-eliminating fix overcomes big problem in 3rd-gen genome sequencing
9. Exome sequencing of health condition extremes can reveal susceptibility genes
10. New genomic sequencing method enables smarter anaysis of individual cells
11. US-Russian collaboration develops new method for sequencing dark matter of life from a single cell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... , June 22, 2015 ... the addition of the "Body-Worn Temperature Sensors ... Trends and Forecast 2014 - 2020" report ... strategic analysis of the global body-worn temperature sensors ... been segmented on the basis of types, care ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... Since the Civil War, the stethoscope has been a ... doctor may be toting another valuable diagnostic tool: a pocket-sized ... of internal medicine at Eastern Virginia Medical School, believes that ... they will become commonplace," he predicts. Dr. Levitov, a ...
... In nature, it,s a dog-eat-dog world, even in ... to disable each other, according to a new study ... in the journal Nature . "The ... ways to control disease-causing pathogens," said Stephanie K. Aoki, ...
... contaminants in the recreational waters at Presque Isle State ... Protection Agency, it was announced today. The ... Science Consortium and Penn State Behrend, will be used ... important human and environmental health implications. Dr. Steven Mauro, ...
Cached Biology News:Author predicts widespread acceptance of pocket-sized ultrasound machines 2Bacteria use 'toxic darts' to disable each other, according to UCSB scientists 2Study eyes fluoxetine in recreational waters 2
(Date:7/7/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... relationship with Illumina (NASDAQ: ILMN ), the global ... will market and sell arrays with Neogen,s custom SNP ... to the global agrigenomics community. Neogen is ... ® genomics laboratory in Lincoln, Neb. ...
(Date:7/7/2015)... , ... July 07, 2015 , ... uBiome, the leading ... to $100,000 of microbiome sampling kits and full 16S laboratory analysis. The goal is ... The winner will also have access to their own dashboard, enabling them to view ...
(Date:7/7/2015)... ND (PRWEB) , ... July 07, 2015 , ... CSM, ... executive team as Vice President of Finance. Morse has an extensive background in financial ... industries to the CSM team. In his new role, Morse will oversee all financial ...
(Date:7/6/2015)... BELLINGHAM, Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... widely used in ophthalmology and other medical fields holds potential to reveal how ... new treatments and reduce stroke-induced damage to the brain. , A new article ...
Breaking Biology Technology:Neogen signs commercialization agreement with Illumina 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3CSM Appoints Michael Morse as Vice President of Finance 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3
... to testing for sleep-related illnesses , , SAN ... of in-home sleep testing and Continuous Positive Airway Pressure ... of the nation,s largest healthcare benefit providers. As a ... able to serve more patients with sleep-related illnesses such ...
... June 16 Strativa Pharmaceuticals, the proprietary products division ... Inc. (NYSE: PRX ), today announced that ... Drug Application (NDA) to the Food and Drug Administration ... buccal tablets, as planned. If approved, Strativa could ...
... , , Harness the Dual Benefits of Freshly ... CHICAGO, June 16 In today,s competitive environment and economic ... a promising new drug compound or chemical entity cannot be ... to do more with less, and productivity and cost savings ...
Cached Biology Technology:SleepQuest Signs National Contract With Aetna 2Strativa's Development Partner, BioAlliance Pharma, Submits Loramyc(R) NDA 2Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 2Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 3Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 4